Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityOther Accumulated ExpensesPayablesReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Short-term Investments (2022 - 2025)

Historic Short-term Investments for CervoMed (CRVO) over the last 5 years, with Q3 2025 value amounting to $17.9 million.

  • CervoMed's Short-term Investments fell 5411.15% to $17.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.9 million, marking a year-over-year decrease of 5411.15%. This contributed to the annual value of $29.9 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that CervoMed reported Short-term Investments of $17.9 million as of Q3 2025, which was down 5411.15% from $25.2 million recorded in Q2 2025.
  • CervoMed's 5-year Short-term Investments high stood at $38.9 million for Q3 2024, and its period low was $3.0 million during Q1 2023.
  • For the 4-year period, CervoMed's Short-term Investments averaged around $22.9 million, with its median value being $22.7 million (2022).
  • In the last 5 years, CervoMed's Short-term Investments tumbled by 8680.9% in 2023 and then plummeted by 2813.95% in 2025.
  • Quarter analysis of 4 years shows CervoMed's Short-term Investments stood at $12.4 million in 2022, then tumbled by 75.89% to $3.0 million in 2023, then skyrocketed by 900.16% to $29.9 million in 2024, then tumbled by 40.32% to $17.9 million in 2025.
  • Its Short-term Investments stands at $17.9 million for Q3 2025, versus $25.2 million for Q2 2025 and $24.7 million for Q1 2025.